FDA Adverse Event Injury Summary report: N

UNK SERI SURGICAL SCAFFOLD

MDR report key: 5775810 · Received July 7, 2016

Report

Report Number
8020862-2016-00036
Event Type
Injury
Date Received
July 7, 2016
Date of Event
April 25, 2016
Report Date
June 10, 2016
Manufacturer
ALLERGAN (MEDFORD)
Product Code
OXF
PMA / PMN Number
K123128
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

MEDWATCH SENT TO FDA ON 07/07/2016. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE EVENTS OF INFECTION AND INADEQUATE TISSUE INGROWTH ARE PHYSIOLOGICAL COMPLICATIONS, AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS. THIS REPORT AND REPORT NUMBER 8020862-2016-00035 WILL BE SUBMITTED FOR THE SAME PATIENT. THIS REPORT IS FOR THE RIGHT SIDE SERI® DEVICE. REPORT NUMBER 8020862-2016-00035 IS FOR THE LEFT SIDE SERI® DEVICE. THE EXPLANTED DEVICE HAS NOT BEEN RETURNED. THEREFORE, NO ANALYSIS OR TESTING HAS BEEN DONE. DEVICE LABELING ADDRESSES THE REPORTED EVENT OF INFECTION AS FOLLOWS: "ADVERSE REACTIONS ARE THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING INFECTION, INFLAMMATION, ADHESION FORMATION, FISTULA FORMATION, AND EXTRUSION."

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE SERI® DEVICE WITH ¿POSSIBLE INFECTION¿ AND ¿SERI® DID NOT INTEGRATE.¿ THE CONCOMITANTLY PLACED SILICONE GEL BREAST IMPLANT WAS EXPLANTED.

Description of Event or Problem · 1

HEALTHCARE PROFESSIONAL REPORTED ADDITIONALLY, "BUT CULTURES WERE NEGATIVE- NO INFECTION FOUND."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
429124 UNK SERI SURGICAL SCAFFOLD MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY OXF ALLERGAN (MEDFORD) NI

Patients

Seq Age Sex Outcome Treatment
1 48 YR Required Intervention